CEO Jazz Pharma Shares Sale: Routine 2,000-Share Exit Leaves Long‑Term Confidence Intact
CEO Ranee GALA’s 2,000‑share sale is a routine 10‑b‑5‑1 move, showing confidence in Jazz Pharma’s strong pipeline and steady upside.
3 minutes to read
JAZZ PHARMACEUTICALS PLC